StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.51−0.08 (-2.23%)

Close on Nov 12, 2026Market cap $30.65MP/E –Yield –

BriaCell Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

BriaCell Therapeutics's EPS for the twelve months ending Apr 30, 2024 was -$188.08. For fiscal 2026 it was -$6.97. The highest annual figure on record is -$6.97 in fiscal 2026.

Annual eps

PeriodPeriod endValueChange
FY2026Jul 31, 2026-$6.97–
FY2025Jul 31, 2025-$62.19–
FY2024Jul 31, 2024-$43.68–
FY2023Jul 31, 2023-$195.00–
FY2022Jul 31, 2022-$259.50–

Quarterly eps

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ1 2026Apr 30, 2026-$0.99–
Q2 FY2026CQ4 2025Jan 31, 2026-$2.58–
Q1 FY2026CQ3 2025Oct 31, 2025-$4.35-127.0%
Q3 FY2025CQ1 2025Apr 30, 2025-$16.42–
Q2 FY2025CQ4 2024Jan 31, 2025-$23.31–
Q1 FY2025CQ3 2024Oct 31, 2024-$32.67–
Q3 FY2024CQ1 2024Apr 30, 2024$16.10–
Q2 FY2024CQ4 2023Jan 31, 2024-$106.40–
Q1 FY2024CQ3 2023Oct 31, 2023-$75.00–
Q4 FY2023CQ2 2023Jul 31, 2023-$22.78–
Q3 FY2023CQ1 2023Apr 30, 2023-$48.00-900.0%
Q2 FY2023CQ4 2022Jan 31, 2023-$115.50–
Q1 FY2023CQ3 2022Oct 31, 2022-$10.50–
Q3 FY2022CQ1 2022Apr 30, 2022-$97.50–
Q2 FY2022CQ4 2021Jan 31, 2022$6.00–

More BriaCell Therapeutics figures

See a number that looks wrong?